Alterations in the DNA topoisomerase IV grlA gene responsible for quinolone resistance in Staphylococcus aureus.
about
DNA gyrase, topoisomerase IV, and the 4-quinolonesSingle-molecule sequencing reveals the molecular basis of multidrug-resistance in ST772 methicillin-resistant Staphylococcus aureus.Rapid exchange of bound ADP on the Staphylococcus aureus replication initiation protein DnaA.Mutations in topoisomerase IV and DNA gyrase of Staphylococcus aureus: novel pleiotropic effects on quinolone and coumarin activity.Cloning and nucleotide sequences of the topoisomerase IV parC and parE genes of Mycoplasma hominis.Characterization of grlA, grlB, gyrA, and gyrB mutations in 116 unrelated isolates of Staphylococcus aureus and effects of mutations on ciprofloxacin MIC.Alterations in topoisomerase IV and DNA gyrase in quinolone-resistant mutants of Mycoplasma hominis obtained in vitroEffects of mutations in GrlA of topoisomerase IV from Staphylococcus aureus on quinolone and coumarin activity.Introduction of a norA promoter region mutation into the chromosome of a fluoroquinolone-susceptible strain of Staphylococcus aureus using plasmid integration.Induction of fibronectin-binding proteins and increased adhesion of quinolone-resistant Staphylococcus aureus by subinhibitory levels of ciprofloxacin.Mechanisms and frequency of resistance to premafloxacin in Staphylococcus aureus: novel mutations suggest novel drug-target interactionsMechanisms and frequency of resistance to gatifloxacin in comparison to AM-1121 and ciprofloxacin in Staphylococcus aureus.Target preference of 15 quinolones against Staphylococcus aureus, based on antibacterial activities and target inhibition.Human serum mannose-binding lectin senses wall teichoic acid Glycopolymer of Staphylococcus aureus, which is restricted in infancy.Antagonism between aminoglycosides and beta-lactams in a methicillin-resistant Staphylococcus aureus isolate involves induction of an aminoglycoside-modifying enzyme.Dual targeting of DNA gyrase and topoisomerase IV: target interactions of garenoxacin (BMS-284756, T-3811ME), a new desfluoroquinolone.Accumulation of mutations in both gyrB and parE genes is associated with high-level resistance to novobiocin in Staphylococcus aureus.Contribution of the 8-methoxy group to the activity of gatifloxacin against type II topoisomerases of Streptococcus pneumoniae.Topoisomerase targeting with and resistance to gemifloxacin in Staphylococcus aureusQuinolone resistance locus nfxD of Escherichia coli is a mutant allele of the parE gene encoding a subunit of topoisomerase IV.Increased expression of fibronectin-binding proteins by fluoroquinolone-resistant Staphylococcus aureus exposed to subinhibitory levels of ciprofloxacin.Association of mutations in grlA and gyrA topoisomerase genes with resistance to ciprofloxacin in epidemic and sporadic isolates of methicillin-resistant Staphylococcus aureusInhibitory activities of quinolones against DNA gyrase and topoisomerase IV purified from Staphylococcus aureus.Mechanisms of fluoroquinolone resistance in genetically related strains of Staphylococcus aureusTopoisomerase IV, not gyrase, decatenates products of site-specific recombination in Escherichia coli.Variety of Antimicrobial Resistances and Virulence Factors in Staphylococcus aureus Isolates from Meat Products Legally and Illegally Introduced to GermanyPleiotropic roles of polyglycerolphosphate synthase of lipoteichoic acid in growth of Staphylococcus aureus cells.Quinolone resistance due to reduced target enzyme expressionWhole genome sequencing reveals high-resolution epidemiological links between clinical and environmental Klebsiella pneumoniae.Evolution of ciprofloxacin-resistant Staphylococcus aureus in in vitro pharmacokinetic environments.Primary targets of fluoroquinolones in Streptococcus pneumoniae.Activities of trovafloxacin compared with those of other fluoroquinolones against purified topoisomerases and gyrA and grlA mutants of Staphylococcus aureus.In vitro activities of six quinolones and mechanisms of resistance in Staphylococcus aureus and coagulase-negative staphylococci.Detection of grlA and gyrA mutations in 344 Staphylococcus aureus strains.Antibacterial activity of gatifloxacin (AM-1155, CG5501, BMS-206584), a newly developed fluoroquinolone, against sequentially acquired quinolone-resistant mutants and the norA transformant of Staphylococcus aureus.Topoisomerase mutations in trovafloxacin-resistant Staphylococcus aureusInhibitory activities of gatifloxacin (AM-1155), a newly developed fluoroquinolone, against bacterial and mammalian type II topoisomerases.Quinolone resistance mutations in the GrlB protein of Staphylococcus aureus.Alteration in the GyrA subunit of DNA gyrase and the ParC subunit of DNA topoisomerase IV in quinolone-resistant clinical isolates of Staphylococcus epidermidis.Examination of methicillin-resistant and methicillin-susceptible Staphylococcus aureus mutants with low-level fluoroquinolone resistance
P2860
Q24643546-B07D0E24-E57C-48AA-B762-3702D7AF5657Q30650682-4C95D214-888C-4A66-8AA6-784F8D407EC4Q33553501-43153640-7131-4E80-9AAB-529A369934B9Q33690598-3BC312F0-080B-44CB-8793-C2E77CB11592Q33694924-CE9BA2F6-48A8-4778-9FFB-69AFB4559099Q33695982-560406BC-5DFC-4E60-8549-5153751A0369Q33696730-EA73E947-A2EC-43B6-8E46-EA1B664B2BF4Q33698247-752F5CCB-C9B8-4FE5-AB17-E76A62BB54A1Q33977640-2A5FCFDA-B593-4437-92D2-E5EFB2667407Q33979593-4CD44FE9-97A6-4DBE-8943-F959E39FCFEEQ33980991-D8E0CA07-9C33-40E2-BE34-0009A0341587Q33983092-D773CD9D-E714-444F-83F9-C0024F9A4CF6Q33983660-FDEE209A-90C0-42E4-A9C3-3439B62C7C47Q34094512-6009B771-645A-4D96-9C17-0C626DDAC024Q34107411-19C6C4EC-AA9A-4DFB-A311-4829EE99FE9EQ34142238-614E4773-DC25-45B1-8233-5A311421F4E6Q34446438-31EC13FD-3A61-4933-AF9B-B3DD0F5E80F1Q34721556-6FB28B3D-E79E-4620-9495-23BFF9CAB24EQ34725095-F7CC1D3A-B5AE-4623-8A85-E6AA26530623Q35131579-B8A0EF03-ABB4-47D0-8447-1A6B0F3EABA4Q35135636-E2AF4001-FCD4-47F9-9200-84E5EE43448FQ35138243-E7B39836-3512-47CF-BE82-D6B459E01236Q35138781-603DDCAD-DF78-404F-A864-03D07D690501Q35139457-D3D550D8-2CFB-4DC3-AAA5-47D8E8EFFDAFQ35192431-61FC3303-4A2B-49D7-B97D-6E57A7F078C8Q36218370-3596F85B-00B7-4C44-8A8D-D2304B3437AEQ37033429-F94F2D03-4C90-47F7-B90A-60D60380BE35Q37062733-EC96F64F-9B77-461C-B310-CDCEAA8A426BQ37604688-F158C2FE-B0C2-428A-BED8-A99585A6E50EQ37624733-E519462F-6D43-4E7E-924D-A2468FB8F10DQ39469902-494DD803-1A09-442D-90D2-1C7D9087BE5EQ39471404-998FE97C-5967-49FD-A52C-AAC9BFEF2E71Q39477241-2F71BA25-3359-4178-A452-5F0E6C244F4CQ39556591-F554E213-C3B0-4D5C-BE46-45C2AF4A2BDEQ39558211-4E2B5FD2-6AA0-436A-BFCF-A6EF2E3D283AQ39559020-143624A9-AC41-440E-BF9C-74EDEC43AAACQ39559188-E5C63C91-C95F-4980-8C91-FD9C27EC4B15Q39559548-31736462-782F-4D75-BC1F-A7CE5AE2CC51Q39559732-C30EAC20-1DB4-4123-873A-E1F0FFC4AA2EQ39559760-F7B766C4-2CC0-4D64-AECF-392DB0827FEA
P2860
Alterations in the DNA topoisomerase IV grlA gene responsible for quinolone resistance in Staphylococcus aureus.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Alterations in the DNA topoiso ...... ance in Staphylococcus aureus.
@en
Alterations in the DNA topoiso ...... ance in Staphylococcus aureus.
@nl
type
label
Alterations in the DNA topoiso ...... ance in Staphylococcus aureus.
@en
Alterations in the DNA topoiso ...... ance in Staphylococcus aureus.
@nl
prefLabel
Alterations in the DNA topoiso ...... ance in Staphylococcus aureus.
@en
Alterations in the DNA topoiso ...... ance in Staphylococcus aureus.
@nl
P2093
P2860
P356
P1476
Alterations in the DNA topoiso ...... tance in Staphylococcus aureus
@en
P2093
Fujimoto K
Nakamura S
Yamagishi J
P2860
P304
P356
10.1128/AAC.40.5.1157
P407
P577
1996-05-01T00:00:00Z